Sort   by:  
 Page size 
Aim of the project was to investigate drug induced proteomic changes in T. brucei within 6 h of treatment with NEU-4438 or SCYX-7158
ORGANISM(S): Trypanosoma brucei 
2023-03-11 | PXD036393 | Pride
SCYX-7158, an oxaborole, is currently in Phase I clinical trials for the treatment of human African trypanosomiasis. Here we investigate possible modes of action against Trypanosoma brucei using a chemo-proteomic approach. SILAC-based proteomic studies using an oxaborole analogue immobilised onto ...
ORGANISM(S): Trypanosoma brucei 
2015-11-25 | PXD002848 | Pride
Oxaboroles target trypanosome CPSF3 - DDD85646 screen
Oxaboroles target trypanosome CPSF3 - Acoziborole screen
Oxaboroles target trypanosome CPSF3 - SCYX-6759 screen
Sort   by:  
 Page size